General Information of the Protein
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Cell Line ID: CL000025 , HEK-293T
Cell Line ID: CL000006 , HEK293
Cell Line ID: CL000001 , Jurkat
Cell Line ID: CL000196 , MDA-MB-468
Cell Line ID: CL000186 , RPMI-8226
Cell Line ID: CL000013 , Sf9
Biochemical Assays
Clinical Information about the Protein
Target 1 ( Opioid receptor sigma 1 (OPRS1) )
Target Type | Successful Target | ||||
---|---|---|---|---|---|
Disease | 6 Target-related Diseases | 6 | |||
1 | Cough [ICD-11: MD12] | ||||
2 | Mood disorder [ICD-11: 6A60-6E23] | ||||
3 | Schizophrenia [ICD-11: 6A20] | ||||
4 | Psychotic disorder [ICD-11: 6A20-6A25] | ||||
5 | Major depressive disorder [ICD-11: 6A70.3] | ||||
6 | Aging skin [ICD-11: EE40] | ||||
Approved Drug(s) | 1 Approved Drug | 1 | |||
1 | Dextromethorphan | Approved | |||
Clinical Trial Drug(s) | 2 Clinical Trial Drugs | 2 | |||
1 | OPC-14523 | Phase 2 | |||
2 | SSR-125047 | Phase 1 | |||
Discontinued Drug(s) | 8 Discontinued Drugs | 8 | |||
1 | BMS-181100 | Discontinued in Phase 3 | |||
2 | Panamesine | Discontinued in Phase 2 | |||
3 | DUP-734 | Discontinued in Phase 1 | |||
4 | Gevotroline | Discontinued in Phase 1 | |||
5 | E-6276 | Terminated | |||
6 | NE-100 | Terminated | |||
7 | PRE-084 | Terminated | |||
8 | Rimcazole | Terminated | |||
Preclinical Drug(s) | 1 Preclinical Drug | 1 | |||
1 | Cutamesine | Preclinical |
Target 2 ( HUMAN opioid receptor sigma 1 (OPRS1) )
Target Type | Unknown Type Target | ||||
---|---|---|---|---|---|
Disease | 2 Target-related Diseases | 2 | |||
1 | Schizophrenia [ICD-11: 6A20] | ||||
2 | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | ||||
Investigative Drug(s) | 4 Investigative Drugs | 4 | |||
1 | Haloperidol | Approved | |||
2 | E-52862 | Investigative | |||
3 | PB28 | Investigative | |||
4 | PD-144418 | Investigative |